Autoren

Barbara attended the University of Illinois in the US and holds a degree in chemistry and microbiology.

Her professional career took her from the University of Washington, to Hybritech and Eli Lilly until she joined Amgen in 2004.  At Amgen Barbara is a Director of Corporate Quality Compliance. She has specialized in Auditing, GMP intelligence and Quality Systems.

Barbara is currently chair of the GMP Intelligence sub-group of the MidWest Discussion group, co-chair of the Rx-360 Monitoring and Reporting Workstream, member of the BIO Manufacturing Working Group and PDA.

Barbara holds an U.S. Patent, is author or co-author of numerous publications and was invited to several conferences and workshops to speak.